ACR 2023 Poster Available on RheumNow: JAKi Safety and Efficacy Through Week 204 in bDMARD-IR Patients with RA View long-term extension outcomes from the SELECT-CHOICE study in bDMARD-IR patients with RA. Sponsored by AbbVie US Medical Affairs. https://t.co/3zEn9a2eml https://t.co/P7QXAmqJ2x